BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28246699)

  • 1. Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.
    Tufman A; Kahnert K; Kauffmann-Guerrero D; Manapov F; Milger K; Müller-Lisse U; Winter H; Huber RM; Schneider C
    Strahlenther Onkol; 2017 May; 193(5):392-401. PubMed ID: 28246699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
    Park H; Dahlberg SE; Lydon CA; Araki T; Hatabu H; Rabin MS; Johnson BE; Nishino M
    Oncologist; 2019 Aug; 24(8):e749-e754. PubMed ID: 30696724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan.
    Sakai K; Kuramoto J; Kojima A; Nishimura H; Kuwabara Y; Toda M; Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Mikami S; Kyoyama H; Moriyama G; Gemma A; Uematsu K
    Int J Clin Oncol; 2019 Dec; 24(12):1549-1557. PubMed ID: 31452019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases.
    Nieder C; Hintz M; Oehlke O; Bilger A; Grosu AL
    Clin Transl Oncol; 2017 Sep; 19(9):1141-1146. PubMed ID: 28357633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer.
    Shin J; Keam B; Kim M; Park YS; Kim TM; Kim DW; Kim YW; Heo DS
    J Thorac Oncol; 2017 Mar; 12(3):520-528. PubMed ID: 27867003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging Lung Cancer: Metastasis.
    Shroff GS; Viswanathan C; Carter BW; Benveniste MF; Truong MT; Sabloff BS
    Radiol Clin North Am; 2018 May; 56(3):411-418. PubMed ID: 29622076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of M descriptors of the 8th edition of TNM classification of lung cancer.
    Dias M; Antunes A; Campainha S; Conde S; Barroso A
    J Thorac Dis; 2017 Mar; 9(3):685-691. PubMed ID: 28449476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
    Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
    Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients.
    Stanic K; Turnsek N; Vrankar M
    Radiol Oncol; 2019 Nov; 53(4):453-458. PubMed ID: 31747381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
    Eberhardt WE; Mitchell A; Crowley J; Kondo H; Kim YT; Turrisi A; Goldstraw P; Rami-Porta R;
    J Thorac Oncol; 2015 Nov; 10(11):1515-22. PubMed ID: 26536193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry.
    Metzenmacher M; Griesinger F; Hummel HD; Elender C; Schäfer H; de Wit M; Kaiser U; Kern J; Jänicke M; Spring L; Zacharias S; Kaiser-Osterhues A; Groth A; Hipper A; Zaun G; Dörfel S; Güldenzoph B; Müller L; Uhlig J; Thomas M; Sebastian M; Eberhardt WEE;
    Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36180086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
    Rami-Porta R; Asamura H; Travis WD; Rusch VW
    CA Cancer J Clin; 2017 Mar; 67(2):138-155. PubMed ID: 28140453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer.
    Kandathil A; Kay FU; Butt YM; Wachsmann JW; Subramaniam RM
    Radiographics; 2018; 38(7):2134-2149. PubMed ID: 30422775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations.
    Feng SH; Yang ST
    Diagn Interv Radiol; 2019 Jul; 25(4):270-279. PubMed ID: 31295144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.
    Fong KM; Rosenthal A; Giroux DJ; Nishimura KK; Erasmus J; Lievens Y; Marino M; Marom EM; Putora PM; Singh N; Suárez F; Rami-Porta R; Detterbeck F; Eberhardt WEE; Asamura H;
    J Thorac Oncol; 2024 May; 19(5):786-802. PubMed ID: 38320664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden.
    Tendler S; Grozman V; Lewensohn R; Tsakonas G; Viktorsson K; De Petris L
    Lung Cancer; 2018 Jun; 120():75-81. PubMed ID: 29748020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.
    Wen J; Chen J; Liu D; Xu X; Fan M; Zhang Z
    Neuroendocrinology; 2020; 110(5):364-376. PubMed ID: 31357196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer.
    Hattori A; Takamochi K; Oh S; Suzuki K
    Jpn J Clin Oncol; 2019 Jan; 49(1):3-11. PubMed ID: 30277521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
    Ou SH; Zell JA
    J Thorac Oncol; 2008 Mar; 3(3):216-27. PubMed ID: 18317063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer.
    Postmus PE; Brambilla E; Chansky K; Crowley J; Goldstraw P; Patz EF; Yokomise H; ; ; ;
    J Thorac Oncol; 2007 Aug; 2(8):686-93. PubMed ID: 17762334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.